Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 30.8B | 30.6B | 32.3B | 30.2B |
Cost of revenue | 12.2B | 12.0B | 14.2B | 11.6B |
Gross profit | 18.7B | 18.6B | 18.1B | 18.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 6.9B | 7.1B | 7.4B | 7.0B |
Other operating expenses | — | — | — | — |
Operating income | 6.5B | 6.3B | 5.3B | 6.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.7B | 1.7B | 1.7B | 1.7B |
Other income expense | 1.3B | 1.4B | 1.6B | -3.4B |
Pretax income | 6.1B | 6.0B | 5.3B | 1.4B |
Tax provision | 1.2B | 1.3B | 900M | 1.3B |
Net income | 4.9B | 4.7B | 4.4B | 145M |
Basic EPS | 0.6 | 0.6 | 0.6 | 0.0 |
Diluted EPS | 0.6 | 0.6 | 0.6 | 0.0 |
Basic average shares | 7.2B | 7.2B | 7.2B | 7.2B |
Diluted average shares | 7.2B | 7.2B | 7.2B | 7.2B |
EBITDA | 13.0B | 13.3B | 12.4B | 12.6B |
Net income from continuing op. | 4.9B | 4.7B | 4.4B | 145M |
Minority interests | -361M | -341M | -328M | -319M |
Preferred stock dividends | — | — | — | — |